BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
ERBB2
,
G-protein-coupled receptor binding
,
Pseudomonas infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Mcl 1
Summary
General Info
Curated Studies
Most Correlated Studies
Mantle cell lymphoma (MCL) gene expression in leukemic blasts of MCL patients and MCL cell lines
Mantle cell lymphoma (MCL) cells treated with kinase inhibitors
Mantle cell lymphoma (MCL) xenografts from bortezomib-resistant and bortezomib-sensitive cell lines
293T embryonic kidney epithelial cell gene expression following inhibition of ERAD
Mantle cell lymphoma cell lines treated with PKC inhibitor AEB071
Explore Curated Studies Results
Literature
Most Relevant Literature
Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative …
Downregulation of miR-125a-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Al…
Targeting MCL-1 in hematologic malignancies: Rationale and progress.
PHLPP1 deficiency ameliorates cardiomyocyte death and cardiac dysfunction through inhibiting Mcl-1 d…
Requirement for antiapoptotic MCL-1 during early erythropoiesis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Mult…
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/M…
Avo In R/R And Previously Untreated MCL
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ